Passing The Torch: Tarver Addresses Audience At FDA Town Hall, Recognizes Shuren’s Accomplishments

In her inaugural address to the medtech industry during the Medtech Conference, acting US CDRH director Michelle Tarver described her mission-driven approach.

From left: Moderator Janet Trunzo and FDA leaders Michelle Tarver, Jeff Shuren, Daniel Caños, Owen Faris and Troy Tazbaz spoke at a town hall during the 2024 Medtech Conference.
From left: Moderator Janet Trunzo and FDA leaders Michelle Tarver, Jeff Shuren, Daniel Caños, Owen Faris and Troy Tazbaz spoke at a town hall. (Brian Bossetta/Citeline)

To kick off the US Food and Drug Administration’s 17 October town hall at the Medtech Conference in Toronto, Michelle Tarver addressed industry for the first time as acting director of the Center for Devices and Radiological Health (CDRH). Tarver became acting director in July after Jeff Shuren announced he was stepping away from the post, which he has held for 15 years.

More from Medtech Insight

More from Policy & Regulation